Specializing in Canadian market entry and commercialization for domestic, U.S., and global life-science companies, from Health Canada submission through access, launch, and scale
​
We drive growth for Pharma, Biotech, Diagnostics, MedTech, and AI Health / Digital Health through four execution steps, with deep expertise post-submission where approval must convert to revenue.
Step 1
Get Approved
Ready for Access
Regulatory and compliance pathways designed for speed and downstream commercialization
-
Health Canada–aligned regulatory strategy
-
Submission planning informed by CADTH, pCPA, INESSS (Quebec), and PMPRB realities
-
Evidence planning to avoid post-approval access and pricing delays
Step 2
Unlock Access
Post-Submission Execution
Hospitals, payers, tenders, and formularies so approval converts to demand
-
CADTH, pCPA, and INESSS (Quebec) execution
-
PMPRB pricing risk and launch sequencing
-
Provincial and Quebec formulary strategy and negotiation support
-
Hospital P&T committee navigation
-
Public-sector RFP and tender strategy, positioning, and execution
Step 3
Build Pipeline
Close Revenue
Sales, BD, partnerships, and field execution that scale — without regulatory risk
-
IDN, academic medical center, and regional health authority access
-
Compliant field force deployment, targeting, and execution
-
KOL and HCP engagement across hospital and community settings
-
Interim commercial leadership when no Canadian affiliate exists
Step 4
Grow Effectively
Scale with Precision
Regulatory-first messaging, governance, and AI-supported decision-making
-
Enterprise CRM execution (Veeva, Salesforce)
-
Advanced territory intelligence and field design
-
Incentive compensation architecture and governance
-
KPI-driven forecasting and performance management
​​
Market Access & Payer Strategy
Evidence to paid claims
-
Executive-led CADTH, pCPA, and INESSS dossier and execution strategy
-
Provincial and Quebec formulary access planning and negotiation support
-
PMPRB-aware pricing and access sequencing
-
U.S. payer evidence translation and value narrative design
-
Accelerated transition from regulatory approval to reimbursed demand
Hospital, Institutional & Field
Go-To-Market
Access is earned inside institutions and sustained in the field.
-
Senior-level P&T committee strategy and navigation
-
RFP and tender strategy, positioning, and execution
-
IDNs, academic medical centers, and regional health authority access
-
Field force deployment, targeting, and compliant execution
-
KOL and HCP engagement across hospital and community settings
Leadership & Team Execution
Execution leadership
-
Build and scale national sales organizations
-
Direct leadership of Regional Sales Managers and field teams
-
C-suite and Managing Director decision support
-
Player-coach operating model focused on execution quality
Commercial Excellence
Precision beats scale
-
Enterprise CRM execution (Veeva, Salesforce)
-
Advanced territory intelligence and field design
-
Incentive compensation architecture and governance
-
KPI-driven forecasting and performance management
Regulatory-First, AI-Enabled
Speed without regulatory risk
-
Health Canada and FDA-aligned execution models
-
Medical Affairs and regulatory governance embedded into GTM
-
PMPRB, CADTH, pCPA, and INESSS policy alignment
-
PAAB- and IMC-aligned promotional and advertising governance
-
Quebec-specific reimbursement, promotional, and language compliance
-
Government and public-sector advertising compliance
-
Senior-governed, glass-box AI decision workflows
-
AI-assisted risk detection, evidence mapping, and reasoning transparency
-
GMP, GCP, and PIPEDA-compliant operations
-
Zero enforcement actions
Launching in Canada
Without a Canadian Affiliate
-
Support U.S. and global life-science companies post-submission
-
Operate Canadian pricing, access, and reimbursement strategy (including Quebec)
-
Execute hospital, public-sector, and field go-to-market activities
-
Provide interim leadership until permanent hiring makes sense
-
Preserve capital while maintaining launch momentum
Supporting Canadian Growth
-
National and provincial market access and hospital execution
-
Commercial and field-team support
-
Interim leadership where required
Therapeutic Areas
Cardiology · Oncology · Rare Disease · Immunology · Neurology · Gastroenterology · Women’s Health · Ophthalmology · Urology · Anesthesiology · Emergency Medicine · Pain · Dermatology
Care Settings & Buyers
Hospitals & Health Systems · Specialty & Retail Pharmacy · Laboratories · Dental · Aesthetic Clinics · Optical · Procurement & Materials Management · Executive Leadership (C-Suite)
Health Technology Modalities
Pharmaceuticals · Biotechnology · Medical Devices · Diagnostics · Digital Health · AI-Enabled Solutions · Imaging & MedTech
Access, Pricing & Policy
CADTH · pCPA · INESSS · PMPRB · Public & Private Formularies · P&T Committees · RFPs & Tenders
Commercial Execution
Patient Support Programs (PSPs) · Commercial Analytics · Decision Intelligence
Specialty Pharma Launch
From Zero to National Leader
​
A global pharmaceutical company lacked Canadian presence. We built their entire operation, regulatory, PSP, commercial and delivered them a top-performing affiliate worldwide.
Health Platform Launch
​Successful scale and Acquisiton
Continuing health education platform faced low physician adoption and exit risk. We rebuilt the GTM strategy, secured KOL support, and drove significant user growth.
​
Diagnostic Lab Launch
​Successful Market Penetration
Through tailored regulatory strategy, compliance navigation, GTM, business development and sales, success was achieved​.​
Commercial Execution
We work to build pipeline, unlock access, and convert approval into revenue
Compliance Growth Advantage
Regulatory discipline is embedded into sales and BD so teams move faster with fewer resets, delays and risk
Execution Intelligence
Senior-governed, glass-box intelligence helps prioritize accounts, surface risk, and support commercial decisions